default author photo

Liru He

Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China

SCHOLARLY PAPERS

2

DOWNLOADS

74

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Safety and Efficacy of Second-Line TKI Plus Anti-PD1 Following Targeted Therapy in Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma: A Real-World Study

Number of pages: 20 Posted: 17 May 2022
Jun Wang, Ruiqi Liu, Wensu Wei, Yang Liu, Zhiling Zhang, Shengjie Guo, Hui Han, Fangjian Zhou, Liru He and Pei Dong
Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China and Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China
Downloads 48 (1,097,529)

Abstract:

Loading...

Immunotherapy, tyrosine kinase inhibitor, safety, efficacy, non clear cell renal cell carcinoma

2.

Phase II Trial of Stereotactic Body Radiotherapy With Sunitinib Versus Sunitinib Alone in Newly Diagnosed Oligometastatic Renal Cell Carcinoma

Number of pages: 28 Posted: 30 Sep 2025
Yang Liu, Xinyue Zhang, Wensu Wei, Ruiqi Liu, Qiwen Pan, Yi-Jun Zhang, Li-Bin Li, Yulu Peng, Tingxuan Huang, Zhiling Zhang, Hui Han, Shengjie Guo, Jianming Gao, Fangjian Zhou, Pei Dong, Liru He and Sneak Peek Administrator
Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - Sun Yat-Sen University Cancer Center, Sun Yat-sen University (SYSU) - Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China and Independent
Downloads 26 (1,372,601)

Abstract:

Loading...

Metastasis-directed therapy, Oligometastatic, Renal cell carcinoma, Stereotactic body radiotherapy, Sunitinib